cGxP.wire https://validator.w3.org/feed/docs/rss2.html Arcturus to Present ARCT-810 Phase 2 OTC Deficiency Data Otsuka Reports Phase 3b SIMTRIYO Data in ADHD and Anxiety PureTech Gains FDA Fast Track for LYT-200 in HR-MDS Alkermes Reports Positive Phase 1b ADHD Data for ALKS 7290 Cue Biopharma Reports Positive Phase 2 CUE-221 Results Tiziana Completes INFORM-MS Phase 2a Trial of Intranasal Foralumab Beacon Therapeutics Reports Positive VISTA Data for Laru-zova Merck Gains Positive EU CHMP Opinion for KEYTRUDA and Padcev Abeona Congratulates Ultragenyx on FAYUVI FDA Approval Sensorium Reports Positive Phase 1a Data for SNTX-2643 Natera Reports Largest Lung Cancer MRD Study for Signatera Quest Diagnostics Finds High Tick-Borne Disease Co-Exposure IMPACT Therapeutics Gains Positive CHMP Opinion for Senaparib Nabsys Advances CRISPR Genome Mapping With New Study Johnson & Johnson Reports Positive CAPLYTA Phase 3 Mania Data Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA Veeva Launches Falcon Router for AI Safety Reporting Merck Launches Your Hive of Whole Health for HIV Care Precigen Gains FDA Platform Designation for AdenoVerse Zealand Pharma Gains Positive CHMP Opinion for Zeydovio Insmed Wins FDA Priority Review for ARIKAYCE sNDA Armata Pharmaceuticals Highlights AP-SA02 Data at ISSSI 2026 Puma Biotechnology Initiates ALISCA-Lung2 Phase II Trial Novo Nordisk Reports Positive Phase 3 CagriSema Resultsx Oracle Health Helps San Juan Regional Improve Patient Flow Specialised Therapeutics Expands Opzelura Partnership in Australia Grünenthal Acquires Stivarga Cancer Treatment From Bayer Concept Medical Presents SirPAD PAD Findings at VIVA 2026 Telix and ITM Announce $1.65B Radiopharmaceutical Merger Abbisko Therapeutics Reports Positive Phase 2 Lavengratinib Data Teva Study Examines Treatment Selection in Schizophrenia Teva Highlights New UZEDY Data in Schizophrenia Care Antengene Advances ATG-022 Into Phase III Gastric Cancer Study Teva Reports New TEV-749 Olanzapine LAI Clinical Data IntraBio Secures FDA Approval for AQNEURSA in A-T HFSA Highlights Late-Breaking Heart Failure Clinical Research Accro Bioscience Advances AC-101 in Ulcerative Colitis CardiaCare Raises Seed Funding for Cardiac Clinical Studies Field Medical Reports 12-Month Field PULSE Trial Results Eli Lilly Wins FDA Approval for Inluriyo-Verzenio Combination Novartis Advances Cosentyx for Polymyalgia Rheumatica AbbVie Reports New Real-World VRAYLAR Data in Depression Lakewood-Amedex Advances Nu-3 Phase 2a Clinical Trial Andelyn Biosciences Advances Commercial Gene Therapy Manufacturing KELLS Gains Singapore HSA Registration for AI Dental Scan LEO Pharma Gains FDA Priority Review for Dersimelagon MaaT Pharma Advances PHOENIX After Negative EMA Opinion Clearmind Briefs FDA on Psychedelic Therapy and Patient Access Adaptive Highlights Updated NCCN MRD Guidance in Multiple Myeloma Hemab Doses First Participant in HMB-003 Phase 1